The third group encompassed 15 carcinomas with synaptophysin-positive cells ranging from 10–29% (15/239; 6%) and the fourth group had 14 carcinomas with a diffuse synaptophysin staining of 30–99% of all tumor cells (14/239; 6%). This evidence concerns the gene SYP and neoplasm.